請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/58030
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 高碧霞 | |
dc.contributor.author | Chia-Chen Yeh | en |
dc.contributor.author | 葉嘉貞 | zh_TW |
dc.date.accessioned | 2021-06-16T08:04:49Z | - |
dc.date.available | 2016-10-09 | |
dc.date.copyright | 2014-10-09 | |
dc.date.issued | 2014 | |
dc.date.submitted | 2014-06-29 | |
dc.identifier.citation | 行政院衛生署(2006).藥你健康-II常見疾病用藥.台北巿:行政院衛生署。
衛生福利部(2010,7月19日).藥品優良臨床試驗準則 (民國 99 年 07 月 19 日修正).取自http://mohwlaw.mohw.gov.tw/Chi/FLAW/FLAWDAT0201.asp 衛生福利部(2012,12月12日).醫療法 (民國 101 年 12 月 12 日修正).取自http:// mohwlaw.mohw.gov.tw /Chi/FLAW/FLAWDAT0201.asp 李育融、葉淑娟(2011).影響參與臨床試驗之動機研究:以健康受試者為例.高雄巿:國立中山大學醫務管理研究所。 周鵾(2010,2月9日).兒童藥物臨床試驗的重要性與特殊性.取自http://journal.9med.net/html/qikan/yx/ekyxzz/200910155/zjlt/20100210092833325_508888.html 邱攻洵(2013).腦膜炎雙球菌.於行政院衛生署疾病管制局、臺灣兒科醫學會、臺灣感染症醫學會編著,感染與疫苗(478-481頁).台北:行政院衛生署疾病管制局。 財團法人台灣醫療改革基金會(2008,11月).醫改會公佈最新兒童用藥調查結果-樂見台灣兒童健康人權的提升.取自http://www.thrf.org.tw/Page_Show.asp?Page_ID=830 張香瑩(2011,10月).台大醫院的兒童用藥安全政策.取自http://epaper.ntuh.gov.tw/health/201110/child_3.html 畢兆偉、石振國(2012).非營利組織社會行銷與關係網絡之探討:以促進兒童用藥安全為例.中華行政學報,137-172。 陳淑姬、周麗婷、林廷華(2007).嬰幼兒健康照護.台北:華杏。 陳棋炎、黃宗樂、郭振恭(2013).民法親屬新論(修訂十一版).台北:三民。 彭子安(2005).用藥安全-淺談兒科用藥疏失.耕莘藥訊,21,1-2 臺灣藥品臨床試驗資訊網(2005,11月28日).民眾對參加臨床試驗應有的認識.取自http://www1.cde.org.tw/ct_taiwan/knowledge.html 歐善福(2009).兒童急性呼吸道感染在不同專科別的門診處方型態與用藥品質之探討.高雄巿:中山大學高階經營碩士學程在職專班 鄭文雄(2009,1月).為孩子提供安全的用藥環境--重視兒童用藥問題.取自http://www.kgh.com.tw/health/18-35.HTML 盧孟珊(2008,10月5日).Taiwan Young Pharmacisits Group會後報告-盧孟珊.取自http://www.typg.org.tw/inside.asp?no=56&cid=10 蘇莉莉(2006).臨床藥品動力學試驗.臨床試驗中英文季刊,2,24-29。 Bartelink, I. H., Rademaker, C. M., Schobben, A. F., & van den Anker, J. N. (2006). Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations. Clinical Pharmacokinetics, 45(11), 1077-1097. Baumgartner, R. M., Taylor, B. J., Peart, N. S., Galland, B. C., & Sayers, R. M. (2001). Participation in research: iInformed consent, motivation and influence. Journal of Paediatrics and Child Health, 37(1), 51-54. Castello, L., Long, P. F., Wong, L. K., Tuleu, C., Yeung, V. (2007). Paediatric Drug Handling. London, UK: Pharmaceutical Press. Council for International Organizations of Medical Sciences. (2002). International Ethical Guidelines for Biomedical Research Involving Human Subjects. Retrieved from http://www.cioms.ch/publications/layout_guide2002.pdf Del Tordello, E., & Serruto, D. (2013). Functional genomics studies of the human pathogen Neisseria meningitidis. Brief Funct Genomics. doi: 10.1093/bfgp/elt018 European Union. (2008). Ethical considerations for clinical trials on medicinal products conducted with the paediatric population. European Journal of Health Law, 15(2), 223-250. Farquhar, C., John-Stewart, G. C., John, F. N., Kabura, M. N., & Kiarie, J. N. (2006). Pediatric HIV type 1 vaccine trial acceptability among mothers in Kenya. AIDS Research and Human Retroviruses, 22(6), 491-495. doi: 10.1089/aid.2006.22.491 Gammelgaard, A., Knudsen, L. E., & Bisgaard, H. (2006). Perceptions of parents on the participation of their infants in clinical research. Archives of Disease in Childhood, 91(12), 977-980. doi: 10.1136/adc.2006.096073 Gammelgaard, A., Knudsen, L. E., & Bisgaard, H. (2006). Perceptions of parents on the participation of their infants in clinical research. Archives of Disease in Childhood, 91(12), 977-980. doi: 10.1136/adc.2006.096073 Glanz, K., Lewis, E. M., & Rimer, B. K. (1997). (Eds.) Health Behavir and Health Education: Theory, Research, and Practice. San Francisco: Jossey-Bass Publishers. Gorsuch, R. L. (1983). Factor analysis (2nd ed.). Hillsdale, NJ:Lawrence Erlbaum. Harth, S. C., & Thong, Y. H. (1990). Sociodemographic and motivational characteristics of parents who volunteer their children for clinical research: a A controlled study. British Medical Journal, 300(6736), 1372-1375. Higgins, P. T. H., Green, S. (2011, March). Cochrane handbook for systematic reviews of interventions. Retrieved from http://handbook.cochrane.org/ Hoberman, A., Shaikh, N., Bhatnagar, S., Haralam, M. A., Kearney, D. H., Colborn, D. K., . . . Chesney, R. W. (2013). Factors that influence parental decisions to participate in clinical research: consenters Consenters vs nonconsenters. Journal of the American Medical Association Pediatrics, 167(6), 561-566. doi: 10.1001/jamapediatrics.2013.1050 Jay, F., Chantler, T., Lees, A., & Pollard, A. J. (2007). Children's participation in vaccine research: Parents' views. Paediatric Nursing, 19(8), 14-18. Kaushal, R., Bates, D. W., Landrigan, C., McKenna, K. J., Clapp, M. D., Federico, F., & Goldmann, D. A. (2001). Medication errors and adverse drug events in pediatric inpatients. Journal of the American Medical Association, 285(16), 2114-2120. Klassen, T. P., Hartling, L., Craig, J. C., & Offringa, M. (2008). Children are not just small adults: The urgent need for high-quality trial evidence in children. Public Library of Science Medicine, 5(8), e172. doi: 10.1371/journal.pmed.0050172 Lincoln, Y. S., & Guba, E. G. (1985). Naturalistic inquiry. California: Sage. Lynn, M. R. (1986). Determination and quantification of content validity. Nursing Research, 35, 382-385. Nabulsi, M., Khalil, Y., & Makhoul, J. (2011). Parental attitudes towards and perceptions of their children's participation in clinical research: A developing-country perspective. Journal of Medical Ethics, 37(7), 420-423. doi: 10.1136/jme.2010.035899 National Institutes of Health. (2012, April 4). How children Benefitbenefit. Retrieved from http://www.nhlbi.nih.gov/childrenandclinicalstudies/childbenefit.php Pasqualetti, G., Gori, G., Blandizzi, C., & Del Tacca, M. (2010). Healthy volunteers and early phases of clinical experimentation. European Journal of Clinical Pharmacology, 7(66), 647-653. doi:10.1007/s00228-010-0827-0 Peden, V., Choonara, I., Gennery, B., Done, H. (2000). Recruiting children to a clinical trial. Paediatric and Perinatal Drug Therapy, 4(2), 75-79. Rosenstock, I. M. (1974). Historical origins of the health belief model. Health Education Monographs, 2(4), 328-335. Rothmier, J. D., Lasley, M. V., & Shapiro, G. G. (2003). Factors influencing parental consent in pediatric clinical research. Pediatrics, 111(5 Pt 1), 1037-1041. Ryan, K. J., Ray, C.G. (2004). Sherris Medical Microbiology (4th ed. ed.). Chicago, Illinois, USA: McGraw Hill. Rylance, G. (1981). Clinical pharmacology. Drugs in children. British Medical Journal (Clinical Research Ed.), 282(6257), 50-51. Sammons, H. M., Atkinson, M., Choonara, I., & Stephenson, T. (2007). What motivates British parents to consent for research? A questionnaire study. Bio-Medical Center Pediatrics, 7, 12. doi: 10.1186/1471-2431-7-12 Shao, P. L., Chang, L. Y., Hsieh, S. M., Chang, S. C., Pan, S. C., Lu, C. Y., . . . Huang, L. M. (2009). Safety and immunogenicity of a tetravalent polysaccharide vaccine against meningococcal disease. Journal of the Formosan Medical Association, 108(7), 539-547. doi: 10.1016/s0929-6646(09)60371-5 Stenson, B. J., Becher, J. C., & McIntosh, N. (2004). Neonatal research: the The parental perspective. Archives of Disease in Childhood: Fetal and Neonatal Edition, 89(4), F321-323. doi: 10.1136/adc.2002.021931 Stunkel, L., & Grady, C. (2011). More than the money: A review of the literature examining healthy volunteer motivations. Contemporary Clinical Trials, 32(3), 342-352. doi:10.1016/j.cct.2010.12.003 Tait, A. R., Voepel-Lewis, T., & Malviya, S. (2003). Participation of children in clinical research: Factors that influence a parent's decision to consent. Anesthesiology, 99(4), 819-825. Tait, A. R., Voepel-Lewis, T., Siewert, M., & Malviya, S. (1998). Factors that influence parents' decisions to consent to their child's participation in clinical anesthesia research. Anesthesia & Analgesia, 86(1), 50-53. Tishler, C. L., & Bartholomae, S. (2002). The recruitment of normal healthy volunteers: A review of the literature on the use of financial incentives. The Journal of Clinical Pharmacology, 42(4), 365-375. doi:10.1177/00912700222011409 Tishler, C. L., & Reiss, N. S. (2011). Pediatric drug-trial recruitment: Enticement without coercion. Pediatrics, 127(5), 949-954. doi: 10.1542/peds.2010-2585 Tzeng, Y. L., & Stephens, D. S. (2000). Epidemiology and pathogenesis of Neisseria meningitidis. Microbes Infect, 2(6), 687-700. U.S. Food and Drug Administration. (2004, October 15). Public health advisory: Suicidality in children and adolescents being treated with anti-depressant medications. Retrieved from http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm155488.htm U.S. Food and Drug Administration. (2011, August 24). Drug research and children. Retrieved from http://www.fda.gov/Drugs/ResourcesForYou/Consumers/ucm143565.htm U.S. Wage and Hour Division. (2010, July). Fact Sheet #28B: FMLA leave for birth, bonding, or to care for a child with a serious health condition on the basis of an “in loco parentis” relationship. Retrieved from http://www.dol.gov/wb/media/Wage_and_Hour_Division_Fact_Sheet_28B.pdf Vanhelst, J., Hardy, L., Bert, D., Duhem, S., Coopman, S., Libersa, C., . . . Beghin, L. (2013). Effect of child health status on parents' allowing children to participate in pediatric research. Bio-Medical Center Medical Ethics, 14, 7. doi: 10.1186/1472-6939-14-7 Vu, D. M., Welsch, J. A., Zuno-Mitchell, P., Dela Cruz, J. V., & Granoff, D. M. (2006). Antibody persistence 3 years after immunization of adolescents with quadrivalent meningococcal conjugate vaccine. Journal of Infectious Diseases, 193(6), 821-828. doi: 10.1086/500512 Waltz, C. F., Strickland, O., & Lenz, E. (1991). Measurement in nursing research (2nd ed.). Philadelphia: F. A. Davis. Waltz, C.F., & Bausell, R. B. (1983). Nursing research: Design, statistics, and computer analysis. Philadelphia: F. A. Davis. Wendler, D., & Jenkins, T. (2008). Children's and their parents' views on facing research risks for the benefit of others. Archives of Pediatrics & Adolescent Medicine, 162(1), 9-14. doi: 10.1001/archpediatrics.2007.3 Wilfond, B. S., & Carpenter, K. J. (2008). Incidental findings in pediatric research. Journal of Law, Medicine & Ethics, 36(2), 332-340, 213. doi: 10.1111/j.1748-720X.2008.00277.x World Health Organization. (1948). Preamble to the constitution. Retrieved from http://www.mentalhealthpromotion.net/resources/preamble-to-the-constitutions-of-the-world-health-organisations.pdf World Health Organization. (2007, September). Promoting safety of medicines for children. Retrieved from http://www.who.int/medicines/publications/essentialmedicines/Promotion _safe_med_childrens.pdf World Medical Association. (2008, October). Declaration of Helsinki: Ethical principles for medical research involving human subjects. Retrieved from http://www.aix-scientifics.com/en/_helsinki2008.html Zupancic, J. A. F, Gillie, P., Streiner, D. L., Watts, J. L., & Schmidt, B. (1997). Determinants of Parental Authorization for Involvement of Newborn Infants in Clinical Trials. Pediatrics, 99(1), e6-e6. doi: 10.1542/peds.99.1.e6 | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/58030 | - |
dc.description.abstract | 研究背景:由世界衛生統計資料顯示兒童用藥錯誤發生率為成人的三倍,其原因為缺乏良好的臨床試驗,來制定出對兒童安全有效的用藥指南,但兒童藥物臨床試驗的困難度主要在受試者招募不易,因兒童臨床試於必須經過父母的同意才可進行,但願意讓小朋友參與臨床試驗的父母屈指可數。
研究目的:本研究以2009~2010年在台灣進行的腦膜炎雙球菌疫苗人體試驗為例,瞭解台灣父母對嬰幼兒臨床試驗的參與意願及影響其意願之相關因素。 研究方法: 本研究運用混合方法(Mixed methods design),以量性為主,質性為輔之研究設計。量性部分以結構性問卷調查,立意取樣臺灣擁有0~2歲之健康嬰幼兒的父母49名;質性部分,以自擬之訪談大綱,立意取樣49名父母中的10名進行訪談,來瞭解父母對嬰幼兒腦膜炎雙球菌疫苗臨床試驗的參與意願及影響其意願之相關因素。 研究結果:34位父母(佔69.38%)是偏向不贊同讓其嬰幼兒去參與這個臨床試驗的,而影響其決定是否參與臨床試驗的五個構面因素中,父母的重視度依序為:試驗的風險及安全性考量(4.13+0.69)、利他人動機(3.56+0.85)、利自己動機(3.54+0.75)、正向經驗及因素的影響及(3.43+0.85)經濟因素的影響(2.82+1.09)。十七項決策因素中,影響父母同意其嬰幼兒參與臨床試驗之相關因素有:對自己的小孩有幫助(r=.52, p<0.01)、可以獲得較多及較佳的醫療照顧(r=.48, p<0.01)、可幫助其他嬰幼兒(r=.34, p<0.05)、可以幫助醫學的進步(r=.35, p<0.05)、與試驗相關的診療,可以免負擔費用(r=.45, p<0.01)、可以獲得額外贈品(r=.44, p<0.01)、有補助車馬費(r=.37, p<0.01)、醫護人員推薦情形(r=.29, p<0.05)。這些決策因素與質性訪談結果相呼應,其主要理由認為臨床試驗的風險其實是很低的,在可以承擔風險,且自己又無損失的情形下,希望可以對醫學有所貢獻。影響其不同意的相關因素有:擔心試驗過程會造成寶寶的不舒服(r=-.36, p<0.05)、覺得自己的孩子被當成試驗品(r=-.39, p<0.01),其主要理由為認為臨床試驗的風險其實是很高的,除非疾病已無藥可治,唯有試驗用藥,不然絕不會讓小朋友參加臨床試驗。父母基本屬性方面,小孩個數多的父母,參與試驗的意願較低;父母的年齡愈大,愈不擔心藥物的副作用(r=-.29, p<0.05);父母的教育程度愈高,對試驗的風險及安全性考量的重視度是愈高的(r=.32, p<0.05)。 結論:研究結果顯示,父母對於嬰幼兒腦膜炎雙球菌疫苗臨床試驗的參與意願是明顯偏低的,其主要理由為對試驗的風險及安全仍有所擔心,不希望小孩成為白老鼠。因此,醫護人員未來在招募未成年受試者時,應多方收集試驗產品的相關安全性數據以供父母參考,以期能提升其參與的意願。 | zh_TW |
dc.description.abstract | Background: According to the data of World Health Statistics, the rate of children’s medication errors is three times that of adults, and one of the reasons is that there is no good clinical study to give a suitable pediatric dosage. The main difficulty of pediatric clinical trials is recruiting volunteers, because clinical trials in children must be under parental consent, but only a handful of parents willing to let children participating in clinical trials.
Purpose: this research study the relevant factors of Taiwan parents’ willingness in participating in clinical trials by the meningococcal vaccine human trials previously conducted in Taiwan between 2009 and 2010, for example. Methods: This study uses a hybrid approach (Mixed methods design), which relies mainly on quantitative method supplemented by qualitative method. Quantitative part structured questionnaire survey, and 49 parents who have 0-2 years of healthy infants in Taiwan are selected by purposive sampling. In qualitative method section, 10 of the 49 parents are selected by purposive sample, and interviewed with author. Results: The results show that 34 parents (representing 69.38%) do not agree to let their children participate in the clinical trial. The five structure factors of parents’ willingness are ranked by the parents’ attention: the risk and safety of clinical trial (4.13+0.69), altruistic motives (3.56+0.85), egoistic motive (3.54+0.75), the influence of positive experience (3.43+0.85), and economic factors (2.82+1.09). The relevant factors of parents’ willingness to let their children participate in clinical trials include: helping their own children (r=.52, p<0.01), getting more and better care (r=.48, p<0.01), helping other infants and toddlers (r=.34, p<0.05), helping medical advances (r=.35, p<0.05), avoiding the burden and costs of trial-related treatment (r=.45, p<0.01), getting extra gifts (r=.44, p<0.01), getting subsidized transportation fee (r=.37, p<0.01), and medical personnel’s recommendations (r=.29, p<0.05). These findings are congruent to the qualitive interviews. The major reason of agreement is that they think the risk of human trial is very low, so they want to help some medical advanced, and do not affect their self-interest. The factors of parents’ unwillingness to participate the trials include: worrying the process of trials will make children uncomfortable (r=-.36, p<0.05), and the consideration of their own children become experimental subjects (r=-.39, p<0.01). The major reason of opposition is the consideration of the safety of clinical trial, so they do not think over trials except there is no remedy for the disease but clinical trial. The significant predictors of parental attributes are the parents who have many children have lower willingness to participate in the human trials (r=-.29, p<0.05); older parents are more willing to have their child participate in clinical trials (r=-.29, p<0.05); more educated parents more likely to attach importance on the risk of clinical trials(r=.32, p<0.05). Conclusion: The results of this study indicate that the parents’ willingness in participating in the meningococcal vaccine human trials is obviously low. The major concerns of parents are the consideration of the risk of clinical trial, and unwillingness to let children become experimental subjects. It is hoped that medical personnel should collect more data or document of safety in the trial to be reference for parents having young children, to increase parents’ willingness at the beginning of recruiting volunteers. | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T08:04:49Z (GMT). No. of bitstreams: 1 ntu-103-R99426003-1.pdf: 1183026 bytes, checksum: fe97ffe0e23faece58911d63f4b2ecbe (MD5) Previous issue date: 2014 | en |
dc.description.tableofcontents | 口試委員審定書 i
致謝 ii 中文摘要 iii Abstract v 第一章 緒論 1 第一節 研究的背景與重要性 1 第二節 研究目的 4 第三節 研究問題 4 第四節 名詞解釋 4 第二章 文獻查證 6 第一節 兒童藥物臨床試驗的重要性 6 第二節 兒童藥物臨床試驗的特殊性 7 第三節 臨床試驗相關知識 8 第四節 腦膜炎雙球菌(Neisseria meningitidis) 9 第五節 影響父母願意或不願意讓其兒童參加臨床試驗的因素 11 第三章 研究方法 15 第一節 研究設計 15 第二節 研究架構 15 第三節 研究對象 16 第四節 研究工具 17 第五節 研究步驟 20 第六節 倫理考量 22 第七節 資料分析 22 第四章 研究結果 23 第一節 研究對象的基本人口學資料 23 第二節 父母對嬰幼兒參與臨床試驗的意願及相關影響因素 26 一、父母對嬰幼兒臨床試驗之參與意願 26 二、影響父母參與嬰幼兒臨床試驗意願之決策因素 26 三、父母的基本屬性和參與意願及決策因素的關聯性 36 第五章 討論 39 第一節 父母對嬰幼兒臨床試驗之參與意願及其決策因素 39 第二節 父母的基本屬性和參與意願及決策因素的關聯性 41 第三節 應用健康信念模式來推廣兒童臨床試驗招募實務 42 第六章 結論與建議 50 第一節 結論 50 第二節 研究限制 51 第三節 應用與建議 52 參考文獻 54 附錄一 嬰幼兒臨床試驗參與意願及相關影響因素問卷 61 第一部份:家長的基本資料 61 第二部份:父母對嬰幼兒參與臨床試驗的意願及相關影響因素 62 一、兒童臨床試驗招募情境 62 二、參與臨床試驗之意願及影響因素 64 附錄二 內容效度評核資料 66 內容效度之專家名單 66 專家審查意見滙整(I) 67 專家審查意見滙整(II) 81 附錄三 質性訪談大綱 96 附錄四 訪談內容逐字稿 97 附錄五 IRB審查同意書 107 | |
dc.language.iso | zh-TW | |
dc.title | 影響父母讓其嬰幼兒參與臨床試驗之意願及其相關因素之探討-以腦膜炎雙球菌疫苗為例 | zh_TW |
dc.title | A Study of the Factors Affecting Parental Decisions Regarding Their Infants or Toddlers Joining the Clinical Trials: An Illustration of Meningococcal Vaccine | en |
dc.type | Thesis | |
dc.date.schoolyear | 102-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 李秉穎,李雅玲 | |
dc.subject.keyword | 臨床試驗,嬰幼兒,父母,參與意願,腦膜炎雙球菌疫苗, | zh_TW |
dc.subject.keyword | clinical trial,infant and toddler,parent,willingness of participation,meningococcus vaccine, | en |
dc.relation.page | 108 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2014-06-30 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 護理學研究所 | zh_TW |
顯示於系所單位: | 護理學系所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-103-1.pdf 目前未授權公開取用 | 1.16 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。